Application Deadline U.S. citizens: 2025-26 Fulbright U.S. Scholar Competition Deadline is Monday, September 16, 2024 at 5 PM EST. Find out more.
Home Country Brazil In Vivo Validation of P2Y2 and P2Y14 Receptor Inhibition as a Therapeutic Strategy for the Treatment of Chronic Fatty Liver Disease Program Fulbright Visiting Scholar Program Program Country Brazil Grant Activity Type Lecturer, Research Discipline Biology Specialization Biochemistry, Biophysics & Molecular Bio Academic Year 2022-2023 Dates March 2023 - June 2023 Flex No Scholar type Non-U.S. (Visiting) Scholar Project Title In Vivo Validation of P2Y2 and P2Y14 Receptor Inhibition as a Therapeutic Strategy for the Treatment of Chronic Fatty Liver Disease Scholar Information Grantee Alexander Henning Ulrich Title Full Professor of Biochemistry Institution Instituto de Qimica, Universidade de Sao Paulo Host Institutions Institution Rutgers, The State University of New Jersey Faculty Andrew Thomas Host Department Department of Pharmacology, Physiology and Neuroscience
In Vivo Validation of P2Y2 and P2Y14 Receptor Inhibition as a Therapeutic Strategy for the Treatment of Chronic Fatty Liver Disease Program Fulbright Visiting Scholar Program Program Country Brazil Grant Activity Type Lecturer, Research Discipline Biology Specialization Biochemistry, Biophysics & Molecular Bio Academic Year 2022-2023 Dates March 2023 - June 2023 Flex No Scholar type Non-U.S. (Visiting) Scholar Project Title In Vivo Validation of P2Y2 and P2Y14 Receptor Inhibition as a Therapeutic Strategy for the Treatment of Chronic Fatty Liver Disease Scholar Information Grantee Alexander Henning Ulrich Title Full Professor of Biochemistry Institution Instituto de Qimica, Universidade de Sao Paulo Host Institutions Institution Rutgers, The State University of New Jersey Faculty Andrew Thomas Host Department Department of Pharmacology, Physiology and Neuroscience